<SEC-DOCUMENT>0001140361-20-014992-index.html : 20200629
<SEC-HEADER>0001140361-20-014992.hdr.sgml : 20200629
<ACCEPTANCE-DATETIME>20200629093015
ACCESSION NUMBER:		0001140361-20-014992
CONFORMED SUBMISSION TYPE:	SC TO-T
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20200629
DATE AS OF CHANGE:		20200629
GROUP MEMBERS:		TTP MERGER SUB, INC.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TETRAPHASE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001373707
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC TO-T
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87366
		FILM NUMBER:		20996064

	BUSINESS ADDRESS:	
		STREET 1:		480 ARSENAL WAY
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617.715.3600

	MAIL ADDRESS:	
		STREET 1:		480 ARSENAL WAY
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC TO-T

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC TO-T
<SEQUENCE>1
<FILENAME>nt10013080x2_sctot.htm
<DESCRIPTION>SC TO-T
<TEXT>
Document 1 - file: nt10013080x2_sctot.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1A
<SEQUENCE>2
<FILENAME>nt10013080x2_ex99-a1a.htm
<DESCRIPTION>EXHIBIT (A)(1)(A)
<TEXT>
Document 2 - file: nt10013080x2_ex99-a1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1B
<SEQUENCE>3
<FILENAME>nt10013080x2_ex99-a1b.htm
<DESCRIPTION>EXHIBIT (A)(1)(B)
<TEXT>
Document 3 - file: nt10013080x2_ex99-a1b.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1C
<SEQUENCE>4
<FILENAME>nt10013080x2_ex99-a1c.htm
<DESCRIPTION>EXHIBIT (A)(1)(C)
<TEXT>
Document 4 - file: nt10013080x2_ex99-a1c.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1D
<SEQUENCE>5
<FILENAME>nt10013080x2_ex99-a1d.htm
<DESCRIPTION>EXHIBIT (A)(1)(D)
<TEXT>
Document 5 - file: nt10013080x2_ex99-a1d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1E
<SEQUENCE>6
<FILENAME>nt10013080x2_ex99-a1e.htm
<DESCRIPTION>EXHIBIT (A)(1)(E)
<TEXT>
Document 6 - file: nt10013080x2_ex99-a1e.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A1F
<SEQUENCE>7
<FILENAME>nt10013080x2_ex99-a1f.htm
<DESCRIPTION>EXHIBIT (A)(1)(F)
<TEXT>
Document 7 - file: nt10013080x2_ex99-a1f.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(D)(2)
<SEQUENCE>8
<FILENAME>nt10013080x2_ex99-d2.htm
<DESCRIPTION>EXHIBIT (D)(2)
<TEXT>
Document 8 - file: nt10013080x2_ex99-d2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(D)(5)
<SEQUENCE>9
<FILENAME>nt10013080x2_ex99-d5.htm
<DESCRIPTION>EXHIBIT (D)(5)
<TEXT>
Document 9 - file: nt10013080x2_ex99-d5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>nt10013080x2_w9-1.jpg
<TEXT>
Document 10 - file: nt10013080x2_w9-1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>nt10013080x2_w9-2.jpg
<TEXT>
Document 11 - file: nt10013080x2_w9-2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>nt10013080x2_w9-3.jpg
<TEXT>
Document 12 - file: nt10013080x2_w9-3.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>nt10013080x2_w9-4.jpg
<TEXT>
Document 13 - file: nt10013080x2_w9-4.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>nt10013080x2_w9-5.jpg
<TEXT>
Document 14 - file: nt10013080x2_w9-5.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>nt10013080x2_w9-6.jpg
<TEXT>
Document 15 - file: nt10013080x2_w9-6.jpg

</DOCUMENT>
</SEC-DOCUMENT>